Watch SNWV. Know when insiders buy.
One email the day a filing lands. Free.
SNWV
SANUWAVE Health, Inc.
4.52
−0.52 −10.32%
USD · close Sep 28
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
61
WATCH · shorts 61
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $38.9MP/E 13.3DIV YIELD —FCF YIELD 10.91%REV TTM $44M +12.7%NET INCOME $15.3MNET DEBT $11.1M52W 4.00 – 40.82SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $9.7M | −3.1% | 76.2% | −$280K | −$682K | −223.8% | -0.08 | $425K | $334K | $91K | Aug 6 |
| Q1 2026 · Mar 31 | $9.6M | +3.1% | 77.3% | −$1.1M | −$1.4M | — | -0.17 | $397K | $23K | $374K | May 12 |
| Q4 2025 · Dec 31derived | $13.4M | +29.7% | 74.7% | $2M | $7.7M | — | 0.20 | $3.3M | $96K | $3.2M | Mar 26 |
| Q3 2025 · Sep 30 | $11.3M | +20.4% | 77.6% | $903K | $9.7M | — | 0.39 | $1.1M | $525K | $556K | Mar 26 |
| Q2 2025 · Jun 30 | $10.1M | +40.4% | 78.1% | $1.4M | $551K | −91.1% | -0.04 | $993K | $1.2M | −$166K | Aug 6 |
| Q1 2025 · Mar 31 | $9.3M | +61.3% | 79.0% | $601K | −$6.1M | — | -0.72 | −$1.5M | $162K | −$1.7M | May 12 |
| Q4 2024 · Dec 31derived | $10.3M | +47.6% | 77.9% | $2M | −$13.3M | −173.0% | -1.12 | $741K | $236K | $505K | Mar 26 |
| Q3 2024 · Sep 30 | $9.4M | +89.0% | 75.5% | $1.5M | −$21.2M | — | -6.65 | $1.3M | $48K | $1.2M | Mar 26 |
| Q2 2024 · Jun 30 | $7.2M | — | 73.2% | $1.6M | $6.2M | — | 0.00 | −$668K | $92K | −$760K | Mar 26 |
| Q1 2024 · Mar 31 | $5.8M | — | 72.6% | −$1.3M | −$4.8M | — | 0.00 | $1.1M | $114K | $986K | Mar 26 |
| Q4 2023 · Dec 31derived | $7M | — | 69.1% | $1M | $18.2M | — | 11.96 | −$1.3M | −$169K | −$1.1M | Mar 20 |
| Q3 2023 · Sep 30 | $5M | — | 71.5% | −$531K | −$23.7M | — | -9.95 | −$2M | $0 | −$2M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $44.1M | 77.1% | $4.9M | $11.8M | 26.8% | 0.41 | $3.9M | $1.9M | $1.9M | — | — |
| FY2024 · to Dec 31 | $32.6M | 75.2% | $3.8M | −$33.1M | -101.4% | -7.41 | $2.5M | $490K | $2M | — | — |
| FY2023 · to Dec 31 | $20.4M | 70.4% | −$540K | −$25.8M | -126.5% | -12.19 | −$4.5M | $0 | −$4.5M | — | — |
| FY2022 · to Dec 31 | $16.7M | 74.1% | −$9M | −$10.3M | -61.5% | -0.02 | −$17.2M | — | — | — | — |
| FY2021 · to Dec 31 | $13M | 61.7% | −$14.1M | −$27.3M | -209.5% | -0.05 | −$6.4M | $529K | −$6.9M | — | — |
| FY2020 · to Dec 31 | $4.1M | 71.4% | −$25.2M | −$30.9M | -762.6% | -0.08 | −$12.7M | $53K | −$12.8M | — | — |
Every number comes from SANUWAVE Health, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.